Business
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
WALTHAM, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today announced that management will participate in the following upcoming investor events: 2026 Jefferies Global Healthcare Conference presentation on Wednesday, June 3rd, 2026, at 12:15 p.m. ET; andGoldman Sachs 47th Annual Global Healthcare Conference 2026 fireside chat on We
About this update from Sionna Therapeutics, Inc.
[{"type":"image","alt":"Sionna Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Sionna Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/9f8d8c0e203777999006c0b8c8d0c418"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tV.lxsbkEH4l9r3Dfcm34Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9f8d8c0e203777999006c0b8c8d0c418","width":300,"height":300},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/tV.lxsbkEH4l9r3Dfcm34Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/9f8d8c0e203777999006c0b8c8d0c418","width":300,"height":300}},"lazy":false},{"type":"text","content":"WALTHAM, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today announced that management will participate in the following upcoming investor events:","length":312,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2026 Jefferies Global Healthcare Conference presentation on Wednesday, June 3rd, 2026, at 12:15 p.m. ET; and","length":108,"tagName":"p"}]},{"val":[{"type":"text","content":"Goldman Sachs 47th Annual Global Healthcare Conference 2026 fireside chat on Wednesday, June 10th, 2026, at 10:00 a.m. ET","length":121,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":229,"olType":false},{"type":"text","content":"Live webcasts can be accessed in the ‘Investors’ section of Sionna’s website at https://investors.sionnatx.com. Replays will also be available following the events.","length":164,"tagName":"p"},{"type":"text","content":"About Sionna Therapeutics Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Sionna’s goal is to deliver differentiated medicines for people living with CF that can restore their CFTR function to as close to normal as possible by directly stabilizing CFTR’s nucleotide binding domain 1 (NBD1), which Sionna believ...